QX-314

CC[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C

InChIKey=PYEBKOFMWAMBFV-UHFFFAOYSA-O

InChI=1S/C16H26N2O/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5/h9-11H,6-8,12H2,1-5H3/p+1

Targets

Primary Target	Pharmacology	Potency
Sodium channel alpha subunits; brain (Types I, II, III) 28 Target ID: CHEMBL2096682 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2579237	Inhibitor 8297	97.0 µM [IC50]
Vanilloid receptor 53 Target ID: CHEMBL4794 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21502857	Modulator 828	8.0 µM [IC50]
Muscarinic acetylcholine receptor M1 169 Target ID: CHEMBL216 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10910501	Antagonist 2778	2.4 mM [IC50]

Name

Type

Language

QX-314

Common Name

English

2-((2,6-DIMETHYLPHENYL)AMINO)-N,N,N-TRIETHYL-2-OXO-ETHANAMINIUM

Common Name

English

TRIETHYL((2,6-XYLYLCARBAMOYL)METHYL)AMMONIUM

Systematic Name

English

Code System Code Type Description

PUBCHEM

3925

Created by admin on Fri Dec 15 19:42:55 GMT 2023 , Edited by admin on Fri Dec 15 19:42:55 GMT 2023

PRIMARY

FDA UNII

46ZIF6Y2X9

Created by admin on Fri Dec 15 19:42:55 GMT 2023 , Edited by admin on Fri Dec 15 19:42:55 GMT 2023

PRIMARY

EPA CompTox

DTXSID10943813

Created by admin on Fri Dec 15 19:42:55 GMT 2023 , Edited by admin on Fri Dec 15 19:42:55 GMT 2023

PRIMARY

CAS

21306-56-9

Created by admin on Fri Dec 15 19:42:55 GMT 2023 , Edited by admin on Fri Dec 15 19:42:55 GMT 2023

PRIMARY

ACTIVE MOIETY


					46ZIF6Y2X9

QX-314

SALT/SOLVATE (PARENT)


					3OYF1S84EN